Publication Name	World Journal of Gastroenterology
Manuscript ID	18374
Country	China

Received	2015-04-18 11:50
Peer-Review Started	2015-04-20 09:59
To Make the First Decision	2015-06-23 14:52
Return for Revision	2015-06-26 13:48
Revised	2015-07-07 17:32
Second Decision	2015-09-12 21:58
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2015-09-14 11:15
Articles in Press	2015-09-14 11:15
Publication Fee Transferred
Edit the Manuscript by Language Editor	2015-10-26 11:49
Typeset the Manuscript	2015-11-27 17:49
Publish the Manuscript Online	2016-01-06 16:13

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Topic Highlights
Article Title	Advances in cryoablation for pancreatic cancer
Manuscript Source	Invited Manuscript
All Author List	Xiao-Mei Luo, Li-Zhi Niu, Ji-Bing Chen and Ke-Cheng Xu
Funding Agency and Grant Number
Corresponding Author	Ke-Cheng Xu, MD, PhD, Guangzhou Fuda Cancer Hospital, School of Medicine, Jinan University, No. 2 Tangdexi Road, Tianhe District, Guangzhou 510665, Guangdong Province, China. xukc@vip.163.com
Key Words	Pancreatic cancer; Cryoablation; Combination therapy; Cryoimmunotherapy
Core Tip	Pancreatic carcinoma is a devastating cancer of the digestive system. The majority of patients present too late to undergo radical surgery and there is no standard treatment for patients with advanced pancreatic cancer. Cryoablation is considered a palliative therapy in the treatment of pancreatic cancer; however, our results suggest that cryoablation may be an effective and safe treatment that can improve survival and quality of life in patients with unresectable or metastatic pancreatic cancer, particularly in combination with other modalities such as 125-iodine seed implantation and immunotherapy. As such, cryoablation may be a potential standard treatment for pancreatic cancer.
Publish Date	2016-01-06 16:13
Citation	Luo XM, Niu LZ, Chen JB, Xu KC. Advances in cryoablation for pancreatic cancer. World J Gastroenterol 2016; 22(2): 790-800
URL	http://www.wjgnet.com/1007-9327/full/v22/i2/790.htm
DOI	http://dx.doi.org/10.3748/wjg.v22.i2.790

Full Article (PDF)	WJG-22-790.pdf
Full Article (Word)	WJG-22-790.doc
Manuscript File	18374-Review.doc
Answering Reviewers	18374-Answering reviewers.pdf
Audio Core Tip	18374-Audio core tip.mp3
Copyright License Agreement	18374-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	18374-Language certificate.pdf
Peer-review Report	18374-Peer-review(s).pdf
Scientific Misconduct Check	18374-Scientific misconduct check.pdf
Scientific Editor Work List	18374-Scientific editor work list.pdf